Metropolitan Life Insurance Company (MetLife)’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,060	Closed	-$85.7K	–	2849
2021 Q3	$85.7K	Buy	+25,060	New	+$77.2K	﹤0.01%	2609
2016 Q2	–	Sell	-37,083	Closed	-$195K	–	2697
2016 Q1	$195K	Hold	37,083	–	–	﹤0.01%	2187
2015 Q4	$291K	Buy	37,083 +1,363	+4%	+$11.7K	﹤0.01%	1993
2015 Q3	$302K	Sell	35,720 -509	-1%	-$4.7K	﹤0.01%	1980
2015 Q2	$397K	Sell	36,229 -2,513	-6%	-$32.3K	﹤0.01%	1912
2015 Q1	$542K	Hold	38,742	–	–	﹤0.01%	1519
2014 Q4	$654K	Hold	38,742	–	–	﹤0.01%	1577
2014 Q3	$520K	Hold	38,742	–	–	﹤0.01%	1692
2014 Q2	$494K	Hold	38,742	–	–	﹤0.01%	1835
2014 Q1	$461K	Hold	38,742	–	–	﹤0.01%	1864
2013 Q4	$535K	Hold	38,742	–	–	﹤0.01%	1771
2013 Q3	$676K	Hold	38,742	–	–	0.01%	1550
2013 Q2	$630K	Buy	+38,742	New	+$1.2M	0.01%	1542

Other funds holding INFI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s INFI Position: Q4 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2021, closing a stake of 25,060 shares — an estimated $85.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in INFI in Q2 2013 and held it in 13 quarters. The position peaked at $676K in Q3 2013. 97 funds tracked by Wall St. Rank hold INFI as of Q4 2021.

Metropolitan Life Insurance Company (MetLife) reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 25,060 Infinity Pharmaceuticals, Inc. shares in Q4 2021, an estimated $85.7K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
Metropolitan Life Insurance Company (MetLife)'s Infinity Pharmaceuticals, Inc. position peaked at $676K in Q3 2013.
97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.